Scalp ageing
co-authored with A. Litus and B. Lytvynenko
A. Litus, B. Lytvynenko, Yu. Ovcharenko. Scalp ageing and associated conditions//Дерматолог. – 2016. – Vol. 07, No. 02. – pp. 198-203 (original in Russian).
Like the skin elsewhere on the body, the skin of the scalp is subject to intrinsic and extrinsic ageing processes. These age-related changes in the scalp are genetically programmed and, as a manifestation of chronological ageing, are regarded as ageing caused by intrinsic factors. The additional age-related changes that result from accumulated adverse environmental exposure, especially ultraviolet irradiation, are classed as ageing caused by extrinsic factors. Observations of skin ageing in general can also be applied to the skin of the scalp. The presence and severity of hair loss is the main factor determining how susceptible the scalp is to photoageing, since the hair coat is an effective natural protection of the scalp against ultraviolet radiation [1]. The effects of ageing on hair-bearing skin are relatively inconspicuous. Under the hair the skin looks pale and dry, with a certain degree of laxity. In contrast, the balding part of the scalp shows signs of photoageing: uneven pigmentation, wrinkles, telangiectasias and precancerous/cancerous conditions, including actinic keratosis, basal cell carcinoma and squamous cell carcinoma. The signs of scalp ageing visible to the naked eye are most pronounced in disorders associated with premature ageing. Children with Hutchinson–Gilford progeria syndrome have thin, lightly pigmented hair and progressive baldness. Dyspigmentation and a visible vascular network appear on the skin. Similar changes are seen when symptoms of progeria develop in adults (Werner syndrome): thinning hair, greying, skin folding, facial ageing and malignant skin tumours [2].
The effect of ultraviolet radiation on hair growth and the condition of the scalp skin
The consequences of prolonged exposure of unprotected skin to ultraviolet radiation (UVR) – mainly photocarcinogenesis and “solar elastosis” – have been studied well enough, yet the effect of UV rays on the course of androgenetic alopecia (AGA) is usually not taken into account. However, some clinical and morphological observations, as well as theoretical considerations, point to a negative effect of UVR.
In essence, the only generally recognised photosensitive dermatoses affecting the scalp are endogenous eczema aggravated by sunlight, dermatomyositis and cutaneous lupus erythematosus. Patients with atopic and seborrhoeic dermatitis sometimes report a non-specific worsening, including of the scalp, after time in the sun; such a flare can be hard to tell apart from increased itching caused by sweating in hot weather.
And while lupus erythematosus is a well-known photosensitive disease that is often accompanied by lesions on the scalp, scalp involvement in dermatomyositis is often overlooked or misdiagnosed.
Moreover, as in patients with lupus erythematosus, patients with dermatomyositis show a significant reduction in the minimal erythema dose (MED) of ultraviolet radiation compared with a healthy control group. Inflammation on the scalp can lead to hair loss [3,4,5,6,7].
Camacho et al. reported a specific type of telogen effluvium triggered by sunburn of the scalp 3-4 months after wearing a hairstyle that left certain areas of the head uncovered during prolonged sun exposure. Its clinical signs also included frontovertical hair loss and a trichogram showing a higher proportion of telogen and dystrophic hairs. The pathomechanism of this type of telogen hair loss has not been established. It has been suggested that the columns of cells in the hair shaft act as a typical efficient fibre-optic system that transmits ultraviolet light down to the hair follicle. Morphologically, the keratinocytes in the hair shaft are arranged in compressed longitudinal columns resembling the coaxial bundles of commercial fibre-optic cables. Thus, the follicular melanocytes of the hair located in the matrix region may act as biosensors of UV rays and respond to incoming light signals. It can also be assumed that, depending on the degree of exposure, UVR may cause photodamage in this area that leads to telogen hair loss [8].
In skin chronically exposed to ultraviolet light, the classic histological changes are dermal elastosis and the deposition of thickened, degraded collagen and elastic fibres. These changes were observed in a study of 140 men with AGA and 50 men without AGA. The study showed that the skin of the balding scalp was characterised by a thickened dermis, mainly due to an increased level of solar elastosis [9]. The study also showed that solar elastosis precedes the onset of AGA, which means that the hair on the head does not provide complete protection against UV radiation. Other features of ageing that may also be seen in UV-exposed scalp skin include marked changes in epidermal thickness and density, an uneven distribution of melanocytes and an increase in inflammatory cells in the skin [10,11].
Intrinsic skin ageing also depends on oxidative stress caused by continuous cellular processes that generate reactive oxygen species (ROS), including superoxide anion, peroxide and singlet oxygen. Studies of cultured fibroblasts have shown that an increase in ROS levels leads to senescence [12]. The many mechanisms by which these species lead to apoptosis include accumulated DNA damage, membrane peroxidation, carbonyl modifications and the loss of protein sulfhydryl groups. In the scalp of a greying person, anagen hair follicles show signs of oxidative stress and apoptosis on immunohistochemical analysis and in cell culture. Melanocyte apoptosis also increased under additional exogenous oxidative stress [13]. The release of ROS as a result of UV irradiation directly causes oxidative damage to proteins in the upper layers of the skin. Some amino acids, such as tyrosine, arginine, cysteine, methionine, proline and threonine, are susceptible to oxidative damage. The structures of skin collagens and elastin are damaged by the formation of intermolecular cross-links that arise under UV irradiation. Such oxidation of skin proteins can lead to a loss of protein function, the loss or gain of enzymatic activity, and increased or decreased susceptibility to degradation [14]. It is also known that ultraviolet irradiation causes photoageing through genetic mechanisms and DNA damage. Mitochondrial DNA undergoes the “common deletion”, the loss of 4977 base pairs, which is seen in many tissues with age. A study of sun-protected skin showed that repeated UV irradiation sessions over 2 weeks increase the dermal mitochondrial common deletion by up to 40%, and this effect appears to persist in most cases even after UV exposure stops. In some cases the size of this common deletion increases 32-fold after 16 months [15]. Indeed, a study of scalp biopsies taken at different times found that the frequency of mitochondrial DNA deletions in hair follicles increases with age. People with greying hair also have a higher level of mitochondrial DNA deletion, which points to similar processes taking place in the scalp [16]. In addition, the inflammatory response appears to be an important part of photoageing. Ultraviolet irradiation activates the transcription factor NF-kB, which induces the expression of pro-inflammatory cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), TNF-α, and adhesion molecules. These cytokines then provide positive feedback, creating a vicious circle that amplifies the effect of UV radiation [17].

Fig. 1. Widespread actinic keratosis of the scalp
Field cancerisation of the bald scalp
The ultraviolet radiation that reaches the Earth's surface spans roughly 290-400 nm. UVB rays (290-315 nm) reach only the upper layer of the dermis, whereas the penetration of UVA rays (315-400 nm) increases with wavelength. Photocarcinogenesis and solar elastosis are the two most serious chronic consequences of ultraviolet radiation acting on the skin and the bald scalp. The ways in which ultraviolet radiation is involved in the development of skin cancer are diverse and form a multistep process that includes changes in DNA structure resulting from the formation of purine photoproducts, cytosine photohydrates, DNA single-strand breaks and sister chromatid exchange, as well as the action of reactive oxygen species produced when ultraviolet radiation acts on cells. In theory, any change capable of causing mutations in specific target genes may contribute to carcinogenesis, since there is a close correlation between mutation and UVR-induced transformation. Specific genes controlling cell growth that may be involved in photocarcinogenesis have recently been identified. In addition, ultraviolet radiation disrupts the mechanisms of immune surveillance, which ultimately favours the survival and progressive growth of UVR-induced malignant tumours. Finally, telomerase activity has been found to play a crucial role in the immortalisation of human cells. Telomerase activity is detected in plucked hair follicles, which is linked to the presence of stem cells in the follicle, as well as in a substantial proportion of skin tumours. Evidence of UVR-associated telomerase activation in human skin further supports the involvement of telomerase activation in skin photocarcinogenesis [18].
Actinic keratosis
Many researchers classify actinic keratosis (AK) as a superficial epithelial tumour, a so-called cancer "in situ", which arises from chronic UVR exposure, usually on sun-exposed areas of the body in middle-aged and older people, including thinning or bald areas of the scalp.
The clinical picture of actinic keratosis (AK) was described by Freudenthal in 1926. In 1958 Pinkus was the first to use the term “actinic keratosis” in his work. Because chronic UV irradiation is accompanied by the proliferation of atypical keratinocytes in the basal layer of the epidermis, AK is also called squamous cell carcinoma in situ (cSCC in-situ). It is difficult to establish a clear rate of malignant transformation, and in most cases AK cannot be distinguished from cSCC in-situ without histopathological examination. Any suspicious-looking lesion therefore requires a biopsy and subsequent treatment.
Actinic keratosis presents as a plaque (skin-coloured to reddish) with ill-defined borders and a dry, firmly adherent crust ( Fig. 1). Actinic keratosis of the scalp, often with multiple lesions, is usually not accompanied by marked symptoms, although slight local tenderness may be noted. Multiple coalescing lesions on the central parietal area affected by androgenetic alopecia are not infrequently mistaken for a refractory form of seborrhoeic eczema of the scalp.
The wide range of clinical and morphological changes that may be present at the same time within the “field of cancerisation” poses a serious diagnostic problem, as it is very difficult to distinguish the early signs of AK from early-stage cSCC clinically.
AK occurs mainly in patients with fair skin, blue eyes and red hair (Fitzpatrick skin types I/II). The risk of AK rises significantly (by 40%) in patients who sunburn easily, compared with people with dark hair and brown eyes [19]. Among Europeans over 40, the prevalence of the condition reaches 6—15%. Men are more prone to AK than women. The risk grows with age: by 20% at 60 and by 52% at 70 [20]. Accordingly, the number of patients with AK has risen markedly over the past 10 years [21]. The reason is demographic change, with older people making up most of the population. People who work outdoors receive high doses of UV and are more prone to AK than office workers [22]. Other risk factors for AK include organ transplantation and/or chronic immunosuppression. After 20 years of immunosuppression the risk of AK is 40—60%, with a high likelihood of malignant transformation into squamous cell carcinoma [23]. The prevalence of AK is linked to chronic exposure to UV light, especially UVB rays. UV radiation causes mutations in the tumour suppressor gene TP53. This gene is located at chromosome locus 17p13.1 and encodes the p53 protein. p53 is an important cell-cycle regulator that induces apoptosis of mutant cells. UV radiation causes a typical cytidine-to-thymidine substitution in TP53. This leads to the inactivation of TP53, followed by uncontrolled proliferation of genetically unstable keratinocytes and the development of AK [24].
Clinically, AK takes many forms, including the classic non-pigmented form, the hypertrophic form, cutaneous horn, the proliferative form, the pigmented form and actinic cheilitis.
It is clinically difficult, and in most cases impossible, to determine the risk of cSCC developing from an individual AK lesion. Quaedvlieg et al. analysed the main clinical signs of malignant transformation and identified the key clinical criteria, combined in the acronym “IDRBEU” (I – Induration/Inflammation, D – Diameter > 1 cm, R – Rapid Enlargement, B – Bleeding, E – Erythema, U – Ulceration). We propose adapting this acronym into an easy-to-remember mnemonic rule, “PIRANHA” (in the Russian original its letters stand for redness/erythema, infiltrate/induration, size over 1 cm, aggressive growth, spontaneous bleeding and ulcer). In our view, this rule brings to mind the danger of an AK lesion transforming into cSCC and can be used both in the clinic and in targeted population screening and skin cancer prevention programmes.
Dermoscopic criteria for a typical non-pigmented AK lesion include a red pseudo-network and dilated follicular openings, often filled with keratin plugs and surrounded by a whitish halo, which creates target-like structures. Together these features are described as a “strawberry” pattern, resembling the surface of a strawberry. In the hypertrophic form of AK, large structureless white or yellow areas appear, corresponding to areas of marked hyperkeratosis.
The histological picture is characterised by parakeratosis. The epidermis may be acanthotic or atrophic. Atypical pleomorphic keratinocytes with large nuclei and scant cytoplasm are found in the lower layers of the epidermis. As AK develops, the number of atypical keratinocytes increases throughout the epidermis. Mitotic figures and dyskeratotic cells are also seen. Solar elastosis and sometimes lymphocytic infiltration are also found. There are several histological variants of AK: pigmented, acantholytic, bowenoid, lichenoid and hypertrophic. Three histological stages of AK progression are also distinguished. When atypical keratinocytes break through the basement membrane, AK transforms into invasive squamous cell carcinoma.
Topical treatments include 5-fluorouracil cream (5, 1, 0.5%), imiquimod cream (5 and 3.75%), a combination of diclofenac sodium 3% gel with 2.5% hyaluronic acid gel, ingenol mebutate gel (0.05 and 0.015%) and cryotherapy. The procedure for treating the “field of cancerisation” is photodynamic therapy with aminolevulinic acid.
With the prevalence of actinic keratosis rising worldwide, and given a deeper understanding of the pathophysiology behind the progression of actinic keratosis to squamous cell carcinoma of the skin, treatment should focus on medicines and procedures that address the entire “field of cancerisation” [25,26,27,28].

Fig. 2. Erosive pustular dermatosis of the scalp
Diagnosis and treatment at the Institute
Get a consultation
Erosive pustular dermatosis of the scalp
Erosive pustular dermatosis of the scalp is a specific disorder typical of the balding scalp. It was first described by Burton, and Pye, Peachey and Burton later defined it as a distinct nosological entity causing extensive chronic pustule formation on the scalp of older people, leading to erosions and scarring alopecia ( Fig. 2).
The frequency of preceding local trauma gives strong grounds to suggest that scalp injury may play an important role in triggering erosive pustular dermatosis of the scalp in predisposed older people with atrophic changes of the scalp skin caused, in particular, by long-term UVR exposure of areas affected by AGA [29,30,31].
The cause of pustule formation has not been established, and the histological features are non-specific. The response to antibiotics is poor, while potent topical steroids are effective, which presumably points to an inflammatory rather than infectious aetiology. The condition is triggered by bruising, cuts, blistering sunburn, herpes zoster, synthetic fibre implantation, craniotomy and scalp skin grafting; it may also occur after treatment of solar keratosis with 5% fluorouracil cream, cryotherapy and topical tretinoin, as well as gentle radiotherapy [32,33,34,35,36].
The histological changes are non-specific. Chronic inflammatory infiltrates with lymphocytes, plasma cells, neutrophils and giant cells are seen. The dermis is usually thinned. A biopsy taken from the edge of an erosion shows atrophic changes of the epidermis. The number of hair follicles is reduced, sometimes with signs of fibrosis [37].
The response to treatment varies: the best response has been recorded with potent topical steroids and, according to recent data, with topical 0.1% tacrolimus. Isolated reports describe a partial response to nimesulide (a phenoxymethane sulfonanilide), which suppresses the functional activity of human granulocytes. Because of reports of neoplastic change, a long follow-up period is recommended [38].
Therefore, when wounds heal slowly after treatment of actinic keratoses of the scalp, the possibility of erosive pustular dermatosis of the scalp should be considered.
Photoprotection
Since all these scalp diseases share a common feature – they are caused or aggravated by sunlight – it has been proposed that optimal protection against photodamage is needed.
Widely used topical chemical agents that act as a protective barrier against the sun are the most convenient means of protecting hairless skin from the acute (sunburn) and chronic harmful effects of ultraviolet radiation. Their use on the scalp (except in complete baldness) is problematic for cosmetic reasons. And although the best way to protect the scalp from ultraviolet radiation is to wear a hat, hats are not comfortable or acceptable for this purpose for every patient.
Despite thorough study of how to protect hair from photoageing, there are no data on photoprotection of the scalp. Hair dyes have been found to have protective properties; experimental work shows that cinnamidopropyltrimonium chloride, a quaternised UV absorber included in a shampoo, provides photoprotection of the hair while conditioning it. Solid lipid nanoparticles have also been developed as new carriers of UV blockers; they can be used on both skin and hair and themselves provide additional photoprotection by reflecting and scattering UV radiation [39, 40].
Finally, a key question of recent research has been systemic photoprotection and the possibility of solving some of the problems associated with topical sunscreens. Preclinical studies have shown photoprotective properties of antioxidant supplements, in particular beta-carotene (provitamin A), α-tocopherol (vitamin E) and L-ascorbate (vitamin C). Nevertheless, clinical evidence that these substances prevent, delay or slow sun damage to the skin has yet to be found. The same applies to topical melatonin, which according to the data blocks UV-induced erythema and the formation of reactive oxygen species in a dose-dependent manner. Nevertheless, these results suggest that it is probably worthwhile combining these compounds with established sunscreens to maximise protection against photodamage [41,42,43,44,45].
References
- Draelos ZD (2000) The biology of hair care. Dermatol Clin 18:651–658
- Nehlin JO, Skovgaard GL, Bohr VA (2000) The Werner syndrome. A model for the study of human aging. Ann N Y Acad Sci 908:167–179
- Dourmishev L, Meffert H, Piazena H (2004) Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed 20:230–234
- Sulica VI, Kao GF (1988) Squamous cell carcinoma of the scalp arising in lesions of discoid lupus erythematosus. Am J Dermatopathol 10:137–141
- Kasteler JS, Callen JP (1994) Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. JAMA 272:1939–1941
- Kligman AM (1979) Perspectives and problems in cutaneous gerontology. J Invest Dermatol 73:39–46
- Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187
- Camacho F, Moreno JC, Garcia-Hernández MJ (1996) Telogen alopecia from UV rays. Arch Dermatol 132:1398–1399
- Sperling LC, Lupton GP (1995) Histopathology of nonscarring alopecia. J Cutan Pathol:97–114
- Trüeb RM (2003) Is androgenetic alopecia a photoaggravated dermatosis? Dermatology 207:343–348
- Piérard-Franchimont C, Uhoda I, Saint-Léger D, Piérard GE (2002) Androgenetic alopecia and stressinduced premature senescence by cumulative ultraviolet light exposure. Exog Dermatol 1:203– 206
- Chen QM, Liu J, Merrett JB (2000) Apoptosis or senescence-like growth arrest: influence of cell- cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J 347:543– 54116
- Arck PC, Overall R, Spatz K et al (2006) Towards a “free radical theory of graying”: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. Faseb J 20:1567–1569
- Yaar M, Gilchrest BA (2007) Photoageing: mechanism, prevention and therapy. Br J Dermatol 157:51–58
- Berneburg M, Plettenberg H, Medve-Konig K et al (2004) Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 122:1277–1283
- Kao SH, Liu CS, Wang SY et al (1997) Ageing- associated large-scale deletions of mitochondrial DNA in human hair follicles. Biochem Mol Biol Int 42:285–298
- Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135–142
- Ueda M, Ouhtit A, Bito T, Nakazawa K, Lübbe J, Ichihashi M, Yamasaki H, Nakazawa H (1997) Evidence for UV-associated activation of telomerase in human skin. Cancer Res 57:370–374
- Traianou A., Ulrich M., Apalla Z. et al. (2012) Risk factors for actinic keratosis in eight European centers: a case-control study. Br J Dermatol; 167 (Suppl 2): 36—42
- Memon A.A., Tomenson J.A., Bothwell J. et al. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154—9
- Schaefer I., Augustin M., Spehr C. et al. Prevalenceand risk factors of keratoses in Germany — analysis of multisource data. J Eur Acad Dermatol Venereol 2013; 28: 309—134
- Hensen P., Müller M.L., Haschemi R. et al. Predisposing factors of actinic keratosis in a North- West German population. Eur J Dermatol 2009; 19: 345—54
- Ulrich C., Schmook T., Nindl I. et al. Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding. Br J Dermatol 2003; 149(Suppl 2): 40—2
- Babilas P., Landthaler M., Szeimies R.M. Actinic keratoses. Hautarzt 2003; 54: 551—62
- Cantisani C, De Gado F, Ulrich M, Bottoni U, Iacobellis F, Richetta AG, Calvieri S (2013) Actinic keratosis: review of the literature and new patents. Recent Pat Inflamm Allergy Drug Discov 7:168–175
- Quatresooz P, Xhaufl aire-Uhoda E, Piérard- Franchimont C, Piérard GE (2009) Epidermal fi eld carcinogenesis in bald-headed: an attempt at fi netuning early noninvasive detection. Oncol Rep 21:1313–1316
- Stockfl eth E (2012) The paradigm shift in treating actinic keratosis: a comprehensive strategy. J Drugs Dermatol 11:1462–1467
- Vatve M, Ortonne JP, Birch-Machin MA, Gupta G (2007) Management of field change in actinic keratosis. Br J Dermatol 157(Suppl 2):21–24
- Burton JL, Peachey RDG, Pye RJ (1988) Erosive pustular dermatosis of the scalp – a definition. Br J Dermatol 119:411
- Pye RJ, Peachey RDG, Burton JL (1979) Erosive pustular dermatosis of the scalp. Br J Dermatol 100:559–566
- Ena P, Lissia M, Doneddu GME, Campus GV (1997) Erosive pustular dermatosis of the scalp in skin grafts: report of three cases. Dermatology 194:80– 84
- Grattan CEH, Peachu RD, Boon A (1988) Evidence for a role of local trauma in the pathogenesis of erosive pustular dermatosis of the scalp. Clin Exp Dermatol 13:7–10
- Laffi tte E, Panizzon RG, Saurat JH (2004) Delayed wound healing on the scalp following treatment of actinic keratoses: erosive pustular dermatosis of the scalp. Dermatol Surg 30:1610
- Trüeb RM, Krasovec M (1999) Erosive pustular dermatosis of the scalp following radiation therapy for solar keratoses. Br J Dermatol 141:763–765
- Lovell CR, Harmann RM, Bradfi eld JW (1980) Cutaneous carcinoma arising in erosive pustular dermatosis of the scalp. Br J Dermatol 102:325–328
- Rongioletti F, Delmonte S et al (1999) Erosive pustular dermatosis of the scalp following cryotherapy and topical tretinoin for actinic keratoses. Clin Exp Dermatol 24:499–500
- Caputo R, Veraldi S (1993) Erosive pustular dermatosis of the scalp. J Am Acad Dermatol 28:96–98. Laffi tte E, Kaya G, Piguet V, Saurat JH (2003) Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. Arch Dermatol 139:712–714
- Pande CM, Albrecht L, Yang B (2001) Hair photoprotection by dyes. J Cosmet Sci 52:377–389
- Wissing SA, Muller RH (2001) Solid lipid nanoparticles (SLN) – a novel carrier for UV blockers. Pharmazie 56:783–786
- Bangha E, Elsner P, Kistler GS (1996) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Arch Dermatol Res 288:522–526
- Fischer TW, Scholz G, Knoll B et al (2001) Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res 31:] 39–45
- Gao T, Bedell A (2001) Ultraviolet damage on natural gray hair and its photoprotection. J Cosmet Sci 52:103–118
- Iyengar B (1998) The hair follicle: a specialized UV receptor in the human skin? Biol Signals Recept 7:188–194
- Starcher B, Pierce R, Hinek A (1999) UVB irradiation stimulates deposition of new elastic fibers by modifi ed epithelial cells surrounding the hair follicles and sebaceous glands in mice. J Invest Dermatol 112:450–455